At low doses, a γ-linolenic acid-lipoic acid conjugate is more effective than docosahexaenoic acid-enriched phospholipids in preventing neuropathy in diabetic rats

Journal of Nutrition

Volumn 137, Issue 2, 2007, Pages 368-372

  Pitel, Séverine ^a   Raccah, Denis ^a   Gerbi, Alain ^a,b,c   Pieroni, Gérard ^a,b,c   Vague, Philippe ^a   Coste, Thierry C ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORN OIL; DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; PHOSPHOLIPID; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; RAT;

RATTUS; ZEA MAYS;

EID: 33846849048     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.2.368     Document Type: Article

References (39)

1. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed. Diabetes Care. 1978;1:168-88.
2. Sima AAF, Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia. 1999;42:773-88.
3. Coste TC, Gerbi A, Vague P, Maixent JM, Pieroni G, Raccah D. Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations: natural sources or biotechnological needs? Cell Mol Biol. 2004;50:845-53.
4. Coste TC, Gerbi A, Vague P, Armand M, Pieroni G, Raccah D. Les supplémentations nutritionnelles en acides gras polyinsaturés dans le traitement de la neuropathie diabetique périphérique. Cah Nutr Diét. 2004;39:185-94.
5. Brenner RR. Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Prostaglandins Leukot Essent Fatty Acids. 2003;68:151-62.
6. Raccah D, Coste T, Gerbi A, Vague P. Acides gras polyinsaturés et diabète. Cah Nutr Diét. 1997;32:349-57.
7. Faas FH, Carter WJ. Altered fatty acid desaturation and microsomal fatty acid composition in the streptozotocin diabetic rats. Lipids. 1980;15:953-61.
8. Hishinuma T, Yu GS, Takabatake M, Nakagawa Y, Ita K, Nishikawa M, Ishibashi M, Suzuki K, Matsumoto M, et al. Analysis of the thromboxane/ prostacyclin balance in human urine by gas chromatography/selected ion monitoring: abnormalities in diabetics. Prostaglandins Leukot Essent Fatty Acids. 1996;54:445-9.
9. Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H, Winter M. Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med. 1979;300:366-7.
10. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;20:649-88.
11. Kitajka K, Puskas LG, Zvara A, Hackler L Jr, Barcelo-Coblijn G, Yeo YK, Farkas T. The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci USA. 2002;99:2619-24.
12. Dines KC, Cotter MA, Cameron NE. Contrasting effects of treatment with omega3 and omega6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia. 1993;36:1132-8.
13. Hounsom L, Horrobin DF, Trischler H, Corder R, Tomlinson DR. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia. 1998;41:839-43.
14. Coste T, Pierlovisi M, Leonardi J, Dufayet D, Gerbi A, Lafont H, Vague P, Raccah D. Beneficial effects of gamma linolenic acid supplementation on nerve conduction velocity, Na+, K+ ATPase activity and membrane fatty acid composition in sciatic nerve of diabetic rats. J Nutr Biochem. 1999;10:411-20.
15. Cotter MA, Cameron NE. Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats. Prostaglandins Leukot Essent Fatty Acids. 1997;56:337-43.
16. Coste TC, Gerbi A, Vague P, Pieroni G, Raccah D. Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy. Diabetes. 2003;52:2578-85.
17. Delzenne NM, Kok NN. Biochemical basis of oligofructose-induced hypolipidemia in animal models. J Nutr. 1999;129:S1467-70.
18. Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AAF, Greene DA. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia. 1993;36:608-14.
19. Yasuda H, Sonobe M, Yamashita M, Terada M, Hatanaka I, Huitian Z, Shigeta Y. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozotocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235. Diabetes. 1989;38:832-8.
20. Djemli-Shipkolye A, Coste T, Raccah D, Vague P, Pieroni G, Gerbi A. Na, K-ATPase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters. Cell Mol Biol. 2001;47:297-304.
21. Bligh EG, Dyer WY. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-7.
22. Ohta A, Mayo MC, Kramer N, Lands WE. Rapid analysis of fatty acids in plasma lipids. Lipids. 1990;25:742-7.
23. Raccah D, Coste T, Cameron NE, Dufayet D, Vague P, Hohman TC. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats. J Diabetes Complications. 1998;12:154-62.
24. Wright RA, Nukada H. Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats. Brain. 1994;117:1395-407.
25. Ruiz-Gutierrez V, Stiefel P, Villar J, Garcia-Donas MA, Acosta D, Carneado J. Cell membrane fatty acid composition in type 1 (insulin-dependent) diabetic patients: relationship with sodium transport abnormalities and metabolic control. Diabetologia. 1993;36:850-6.
26. Huang YS, Horrobin DF, Manku MS, Mitchell J, Ryan MA. Tissue phospholipid fatty acid composition in the diabetic rat. Lipids. 1984;19:367-70.
27. Chattopadhyay J, Thompson EW, Schmid HH. Nonesterified fatty acids in normal and diabetic rat sciatic nerve. Lipids. 1992;27:513-7.
28. Gerbi A, Maixent JM, Barbey O, Jamme I, Pierlovisi M, Coste T, Pieroni G, Nouvelot A, Vague P, et al. Alterations of Na, K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids. J Neurochem. 1998;71:732-40.
29. Gerbi A, Maixent JM, Ansaldi JL, Pierlovisi M, Coste T, Pelissier JF, Vague P, Raccah D. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J Nutr. 1999;129:207-13.
30. Cameron NE, Cotter MA, Hohman TC. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia. 1996;39:172-82.
31. Cameron NE, Cotter MA, Horrobin DF, Tritschler HJ. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia. 1998;41:390-9.
32. Wright RA, Nukada H. Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats. Brain. 1994;117:1395-407.
33. Poschl JM, Leray C, Groscolas R, Ruef P, Linderkamp D. Dietary docosahexaenoic acid improves red blood cell deformability in rats. Thromb Res. 1996;81:283-8.
34. Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Lund DD. Effect of Fidarestat and a-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction. Exp Diabesity Res. 2004;5:123-35.
35. Iijima S, Otsuka F, Kikuchi H, Yamada K, Nakajima T, Yahiro K, Kondo A. Oral supplementation with gamma-linolenic acid extracted from Mucor circinelloides improves the deformability of red blood cells in hemodialysis patients. Nephron. 2000;86:122-8.
36. Jiang WG, Redfern A, Bryce RP, Mansel RE. Peroxisome proliferators activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells. Prostaglandins Leukot Essent Fatty Acids. 2000;62:119-27.
37. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002;53:409-35.
38. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006;1:420-39.
39. Berger A, Roberts MA, Hoff B. How dietary arachidonic-and docosahexaenoic-acid rich oils differentially affect the murine hepatic transcriptome. Lipids Health Dis. 2006;5:10.